文献速递鼻科头颈外科

复发性鼻窦恶性肿瘤的症状出现率低于其他头颈部复发性肿瘤:一项多机构研究

Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi-institutional study.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-02-15

该多机构研究在3个学术鼻科与颅底外科中心识别55例根治性治疗后复发的鼻窦恶性肿瘤患者,51%的患者在肿瘤复发时无可疑症状,平均复发时间为33个月;男性和IVA期或更低分期患者更可能无症状(p<0.05)。作者认为鼻窦恶性肿瘤复发时症状出现率远低于头颈部肿瘤总体,且复发时间更长,需更个体化的监测方案。

要点

  • 51%的鼻窦恶性肿瘤患者在复发时无可疑症状,平均复发时间33个月。
  • 男性和IVA期或更低分期患者复发时更可能无症状(p<0.05)。
  • 鼻窦恶性肿瘤复发时症状出现率低于头颈部肿瘤总体,复发时间更长。

核心结论

  • 鼻窦恶性肿瘤患者肿瘤复发期间的症状出现率远低于头颈部肿瘤总体观察到的水平,且复发时间明显更长,多数头颈部肿瘤复发发生在治疗后前12个月内;这些差异突出表明对根治性治疗的鼻窦肿瘤病史无症状患者需要更个体化的监测模式。

研究设计与样本

  • 在3个学术鼻科与颅底外科中心识别鼻窦恶性肿瘤复发患者,收集人口学、肿瘤和治疗数据,统计就诊时症状出现率并结合其他变量分析。

主要发现

  • 55例患者根治性治疗后鼻窦恶性肿瘤复发。
  • 51%的患者在肿瘤复发时无可疑症状,平均复发时间33个月。
  • 男性患者和IVA期或更低分期疾病患者在复发时显著更可能无症状(p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sinonasal malignancies are a rare subset of head and neck tumors, and surveillance strategies after definitive tumor treatment are often generalized from those for overall head and neck cancer outcomes data. However, recent literature suggests that the posttreatment period in sinonasal cancer is fundamentally different and a more tailored surveillance approach may be beneficial. Although rates of symptomatology are high in head and neck cancer recurrence and patient-driven follow-up is common, rates of symptomatology are unknown in sinonasal cancer specifically. METHODS: Patients with recurrence of sinonasal malignancy were identified at 3 academic rhinology and skull base surgery centers. Demographic, tumor, and treatment data were collected. Rates of symptomatology at presentation were tabulated and examined in the context of several other variables. RESULTS: Fifty-five patients had recurrence of sinonasal malignancy after definitive treatment. Fifty-one percent of patients had no suspicious symptoms at the time of tumor recurrence, with an average time to recurrence of 33 months. Male patients and patients with stage IVA or lower disease were significantly more likely to be asymptomatic at the time of recurrence (p < 0.05). CONCLUSION: Patients with sinonasal malignancy have a much lower rate of symptomatology during tumor recurrence than that observed in head and neck cancer overall. Furthermore, time to recurrence is substantially longer, as a majority of head and neck cancer recurrences occur in the first 12 months after treatment. These differences highlight the need for more tailored surveillance paradigms in asymptomatic patients with a history of a definitively treated sinonasal neoplasm.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Workman AD, Velasquez N, Khan NI, et al. Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi-institutional study. Int Forum Allergy Rhinol. 2019. PMID: 30768764. doi:10.1002/alr.22310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。